HHS IG Audit: 'Medicare and Some Enrollees Paid Substantially More When Stelara Was Covered Under Part D Versus Part B'
August 26, 2024
August 26, 2024
WASHINGTON, Aug. 26 -- The Health and Human Services Inspector General issued the following audit report (No. OEI-BL-19-00500) on Aug. 6, 2024, entitled "Medicare and Some Enrollees Paid Substantially More When Stelara Was Covered Under Part D Versus Part B" filed under the Centers for Disease Control and Prevention.
Here are excerpts:
* * *
Report Highlights
Why OIG Did This Review
Stelara is a high-cost prescription bio . . .
Here are excerpts:
* * *
Report Highlights
Why OIG Did This Review
Stelara is a high-cost prescription bio . . .